Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Loud And Clear: EMA Gets Message On Advancing Reg Science

Challenge Is Making Headroom To Discuss Implementing The Changes

Executive Summary

The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.

You may also be interested in...



EU Panel Sets Ambitious Big Data Workplan

An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.

Single Annual EMA Fee Proposal Holds Most Promise For Pharma

Europe’s research-based industry association picks its preferred way forward for simplifying the European Medicines Agency’s fee system.

UK Tackles GCP Concerns Over Electronic Health Records

As NHS Trusts switch from paper-based to electronic health records, concerns have arisen about the compatibility of EHR systems with the clinical trials legislation in some cases.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel